Nanotechnology debate at Nottingham

I don’t know about anybody else, but I enjoyed yesterday’s nanotechnology debate at Nottingham. The whole thing was filmed, and as soon as it’s been edited and tidied up we’ll get the video put up on the web. Given that everyone will soon have the opportunity to judge for themselves how the thing went, I’ll confine myself here to some general observations. There was a big crowd, mostly graduate students attending the surface science summer school, supplemented by a good fraction of the local nanoscientists. The nature of the audience meant that the debate rapidly got quite technical; I don’t think anyone could say that the molecular manufacturing point of view didn’t get a serious hearing. I must say that I was a little apprehensive, given the rancour that has entered previous debates, but I felt the tone was robust but mutually respectful.

My prize for gnomic aphorism of the evening goes to my fellow-panellist Saul Tendler (bionanotechnologist and pharmacy professor). “If a cat had wheels, who would change its tyres?”

Nanotechnology and human enhancement

A session at the British Association’s annual meeting in September, which this year is being held in Dublin, is devoted to a debate on the topic “Should we enhance ourselves: does nanotechnology have limits”. The debate, which is between 7 pm and 9 pm on Tuesday 6 September, has been put together by Donald Bruce, the Director of the Church of Scotland’s Science, Religion and Technology Project. The speakers are myself, Donald, and Paul Galvin, teamleader for Nanobiotechnology at the Tyndall National Institute in Cork.

Under attack

Soft Machines is currently the victim of what amounts to a denial of service attack. This post is by way of warning that the site may need to be taken down (temporarily, I hope) later today if it can’t be sorted out.

Update 20 August. There’s been a bit of improvement, following various measures. Data transfer (normally 20-30 MB a day) is back to about 50 MB a day, from a high of 500 MB a day. I’ve made my peace with the web hosting company. But I do need to move the site onto a different server, which is proving to be a bit of a pain, and means that I’m needing to find out more about mySQL than I really want to know.

22 August. The site is now on the new server. I hope most things have transferred ok; please let me know if you find any glitches. The last four comments – from Kurt, Howard Salis, and replies from me to each – aren’t registered in the “Recent Comments” sidebar, but can be found in the appropriate posts, “commercialising synthetic biology” and “cheap designer genes”.

Cheap designer genes

The kind of DNA-based nanotechnology pioneered by New York University’s Ned Seeman is currently the closest thing we have to the radical aim of making nanoscale structures and machines with atomic precision, but the development of the technology is limited by cost. DNA is an expensive molecule – currently it costs about $5000 a gram to make short, synthetic DNA sequences.

The cost of synthetic DNA has been dropping, but a new company is promising orders of magnitude drops in cost for much longer sequences of DNA. The company, Codon Devices, is commercialising methods developed in George Church’s group at Harvard Medical School – the method is describe in this Nature paper (subscription required for full paper): Accurate multiplex gene synthesis from programmable DNA microchips.

It’s not DNA nanotechnology that the company cites as its major potential market, though. Their ambition is to make synthetic genes for synthetic organisms, in the emerging field of synthetic biology.

The big picture on nanoscience

The Wellcome Foundation – one of the world’s largest biomedical research charities – has released a 16 page briefing document on nanoscience and nanotechnology intended for science teachers and post-16 students. It can be downloaded as a PDF from the associated web-pages – The Big Picture on Nanoscience – which are well-supplied with additional web-based resources and also have instructions for ordering the print version.

The document seems pretty exemplary to me – well and punchily written by some excellent science writers, well-illustrated and covering most of the points in a pretty balanced way. It’s particularly good on the debate about risks and potential downsides of nanotechnology.

The highlight for me is this nanointerview with two people from different sides of the debate – Doug Parr, Chief Scientist of Greenpeace, and Mark Welland, director of the Cambridge Nanoscience Centre. It’s a model of thoughtful debate with each protagonist looking cooly at both sides of the argument. Many people will welcome this statement from Doug Parr: “There isn’t big public opposition to nanotechnologies. Greenpeace isn’t opposed to them either: I hope some good things will come out of them. But we do have some scepticism about how they will be shaped.”

One year of Soft Machines

It’s just over a year since I became the proud owner of the domain softmachines.org and managed a basic WordPress installation. At the time I thought to myself “I’ll just get this working, and then make it pretty later”, but of course I never actually got around to much in the way of cosmetic improvement. Let me say to the various people who have emailed me with very sensible suggestions about how to make the site better, thank you for your input, and I still hope to get around to implementing some of them one day…

Looking back on the expectations I had starting out, it’s clear that things haven’t unfolded the way I planned. I’ve certainly spent much less time than I thought I would talking about my own research. I’ve certainly not filled the blog with details of my day-to-day life (maybe that’s a pity – one of my colleagues, when I announced last year that I was starting a blog, said rather caustically “Good – maybe now your graduate students might have some idea where you are when they try in vain to find you”). I’ve probably spent more time than I anticipated discussing MNT, and issues around public engagement and public acceptance seem to have loomed larger than I would have predicted. But I’m happy that the blog has developed a steadily growing readership of a very worthwhile size, and I am continually surprised at the number of people I meet who say they look at it.

Soft machines site statistics

I have some ideas about how the site might develop next year. One thing I hope to do is increase visual impact of the site by including more images; another long overdue task is to go over the archives and arrange some of the more durable entries in a more logical and accessible way. In terms of the balance of the subject matter (or anything else, for that matter), any suggestions are welcome. Ultimately, though, perhaps the best I can hope for is just to try to follow this fascinating and unpredictable subject in whichever direction the advancing science and unfolding debate takes it.

Soft Machines at the Foresight Conference

The newly relaunched Foresight Institute – now officially the Foresight Nanotech Institute, with a mission of “Advancing Beneficial Nanotechnology” – holds its annual conference from October 22 to 27th in San Francisco. I was very pleased to get an invitation to talk in the first part of the meeting – the Vision Weekend. I’ll be taking the opportunity to set out some of my more speculative thoughts about how we might learn lessons from nature to make a radical nanotechnology based on some of the design principles used by cell biology.

All things begin & end in Albions ancient Druid rocky shore

Soft Machines is taking a short break – I’m going to the seaside with my family for a week and will be away from internet contact. My apologies in advance for any comment spam that gets through the filters.

I always like to be on vacation on July 4th; it’s both my wedding anniversary and my son’s birthday. For any readers who might have any other reason to celebrate that day, have a happy holiday.

Biomimetic nanotechnology with synthetic macromolecules

This is a draft of a piece I’ve been invited to write for the special edition of Journal of Polymer Science: Polymer Physics Edition that is associated with the March meeting of the American Physical Society. The editors invited views from a few people about where they saw the future of polymer science. Here’s my contribution, with themes that will be familiar to readers of Soft Machines. Since the intended audience consists of active researchers in polymer science, the piece has more unexplained technical language than I usually use here.

In the first half of the twentieth century, polymer science and biochemistry developed together. With synthetic polymer chemistry in its infancy, most laboratory examples of macromolecules were of natural origin, and the conceptual foundations of polymer science, such as Staudinger’s macromolecular hypothesis, were as important for biology as for chemistry. Techniques for the physical characterisation of macromolecules, like Svedberg’s ultracentrifuge, were applied as much to biological macromolecules as synthetic ones. But with the tremendous development of the field of structural biology that x-ray protein crystallography made possible, the preoccupations of polymer science increasingly diverged from those of what was now being termed molecular biology. The issues that are so central to protein structure – secondary and tertiary structural motifs, ligand-receptor interactions and allostery, had no real analogue in synthetic polymer science. Meanwhile, the issues that exercised polymer scientists – crystallisation, melt dynamics and rheology – had little relevance to biology. Of course there were exceptions, but conceptually and culturally the two disciplines had become worlds apart.

I believe that the next fifty years we need to see much more interaction between polymer science and cell biology. In polymer science, we’ve seen the focus shift away from the properties of bulk materials to the search for new functionality by design at the molecular level. In cell biology, the new methods of single molecule biophysics permit us to study the behaviour of biological macromolecules in their natural habitat, rather than in a protein crystal, allowing us to see how these molecular machines actually work. Meanwhile synthetic polymer chemistry has started to give us access to control over molecular architecture. This is not yet at the precision that we obtain from biology, but we are already seeing the exploitation of non-trivial macromolecular architectures to achieve control over structure and function. The next stage is surely to take the insights from single molecule biophysics about how biological molecular machines work and design synthetic molecules to perform similar tasks.

We could call this field biomimetic nanotechnology. Biomimetics, of course, is a well-known field in material science; what we are talking about here is biomimetics at the level of single molecules, at the level of cell biology. Can we make synthetic analogues of molecular motors and other energy conversion devices? Can we learn from membrane biophysics to make selective pumps and valves, which would allow the easy and energy-efficient separation and sorting of molecules? Will it be possible to create any synthetic analogue of the systems of molecular sensing, communication and computation that systems biology is just starting to unravel? It’s surely only by achieving this degree of nanoscale control that the promise of molecular medicine could be fulfilled, to give just one example of a potential application.

What are the areas of polymer science that need to be advanced to enable these developments? Obviously, in polymer chemistry, synthesis with precise architectural control is key, and achieving this goal in water-soluble systems is going to be important if this technology is going to find wide use, particularly in medical applications. Polymer physicists are still much less comfortable dealing with systems involving water and charges than with polymer solutions in simple non-polar solvents, and we’ll need more work to ensure that we have a good understanding of the physical environment in which our devices will be operating.

The importance of self-assembly as a central theme will continue to grow. This way of creating intricate nanostructures by programmed interactions in macromolecules is well known to polymer science; the richness of the morphologies that can be obtained in block copolymer systems is well-known. But in comparison with the sophistication of biological self-assembly, synthetic self-assembly still operates at a very crude level. One new element that we should import from biology is the exploitation of secondary structure and its coupling to nanoscale morphology. Another important idea is to exploit the single chain folding of a sequenced copolymer in an analogue of protein folding. This, of course, would require considerable precision in synthesis, but theoretical developments are also necessary. We have learnt from the theory of protein folding theory that only a small fraction of possible sequences are foldable, so we will need to learn how to design foldable sequences.

Another important principle will be exploiting molecular shape change. In biology, this principle underlies the operation of most sophisticated nanoscale machines, including molecular motors, ion channel proteins and signalling molecules. In polymer physics the phenomenon of the coil-globule transition in response to changing solvent conditions is well known and has its macroscopic counterpart in thermoresponsive gels. To be widely useful, we need to engineer responsive systems with much more specific triggers and with a more highly amplified response. One promising way of doing this uses the coupling between transitions in secondary structure and global conformation; however we’re still a long way from the remarkable lever arms of biological motor proteins, in which rather subtle changes at a binding site produce a large overall mechanical response.

Some of the most powerful ideas from biology still remain essentially unexploited. An obvious one is, of course, evolution. At the molecular level, evolution offers a spectacularly powerful way of searching multidimensional parameter spaces to find efficient design solutions. It’s arguable that, given the combinatorial complexity that arises with even modest degrees of architectural control and our unfamiliarity with the design rules that are appropriate for the nanoscale environment, that significant progress will positively require some kind of evolutionary approach, whether that is executed in computer simulation or with real molecules.

Perhaps the most fundamental difference between the operating environments of biology and polymer science is the question of thermodynamic equilibrium. Polymer scientists are used to systems at, or perturbed slightly away from, equilibrium, while biological systems are driven far from equilibrium by a continuous energy input. How can we incorporate this most basic feature of life into our synthetic devices? What will be our synthetic analogue of life’s universal energy currency, adenosine triphosphate?

Ultimately, what we are talking about here is the reverse engineering of biology. It’s obvious that the gulf between the crudities of synthetic polymer science and the intricacies of cell biology is currently immense (certainly quite big enough to mean that the undoubted ethical issues that would arise if we could make any kind of reasonable facsimile of life are still very distant). Nonetheless, even rudimentary devices inspired by cell biology would be of huge practical benefit. Potentially even more significant a benefit than this, though, would be the deep understanding of the workings of biology that would arise from trying to copy it.

Nanotechnology theme day

The UK’s funding agency for the physical sciences – the Engineering and Physical Science Research Council (EPSRC) – has been holding a theme day to review the nanotechnology it supports. All holders of grants in the nanotechnology area were invited to present their work. A panel of academic and industrial scientists and engineers, with international representation from the USA and Korea, reviewed the work presented on the day, as well as reports on recently finished grants and other evidence in an attempt to assess the health of the subject, to judge the UK’s position in relation to the rest of the world and to make recommendations.

Unlike most other countries, the UK doesn’t have a coordinated nanotechnology program. There are two interdisciplinary research collaborations, based at Oxford and Cambridge respectively, but most funding is provided in response to individual grant applications which are made, not to a single nanotechnology program, but to panels dealing with chemistry, physics, materials or information technology. The last time that nanotechnology was reviewed in this way was in 1999, and at that time it was felt that a single nanotechnology program was not needed.

I was on the panel; the report will be made public when it is finalised, so it’s probably premature to go into details about the conclusions we reached. As they say in diplomatic communiques, the discussions were full and frank, but we finished in remarkable agreement.